Sean F. Gilmore Physical and Life Sciences Directorate Lawrence Livermore National Laboratory Biography Publications Institution JoVE Articles Sean F. Gilmore has not added a biography. If you are Sean F. Gilmore and would like to personalize this page please email our Author Liaison for assistance. Publications A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections Frontiers in Pharmacology. 2021 | Pubmed ID: 34899322 Induction of Protection in Mice Against a Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles Vaccines. Jul, 2021 | Pubmed ID: 34358171 Characterization of Spore Proteins Using a Nanoscaffold Vaccine Platform Frontiers in Immunology. 2020 | Pubmed ID: 32714323 Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer Cancers. May, 2020 | Pubmed ID: 32455670 Macromolecular Gelatin Properties Affect Fibrin Microarchitecture and Tumor Spheroid Behavior in Fibrin-gelatin Gels Biomaterials. 08, 2020 | Pubmed ID: 32334200 Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo Cancers. Mar, 2020 | Pubmed ID: 32183351 HIV Influences Microtubule Associated Protein-2: Potential Marker of HIV-associated Neurocognitive Disorders AIDS (London, England). 06, 2020 | Pubmed ID: 32073448 Lipid Composition Dictates Serum Stability of Reconstituted High-density Lipoproteins: Implications for in Vivo Applications Nanoscale. Apr, 2018 | Pubmed ID: 29564446 Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake ACS Applied Materials & Interfaces. Aug, 2016 | Pubmed ID: 27411034 Cellefri skaleret produktion og adjuvans tilsætning til et rekombinant større ydre membranprotein fra Chlamydia muridarum til vaccineudvikling Sean F. Gilmore*1, Wei He*1, Angela C. Evans1, Delia F. Tifrea2, Sukumar Pal2, Brent Segelke1, Sandra K. G. Peters1, B. Dillon Vannest1, Nicholas O. Fischer1, Amy Rasley1, Luis M. de la Maza2, Matthew A. Coleman1,3 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 2Department of Pathology and Laboratory Medicine, University of California, 3School of Medicine, Radiation Oncology, University of California Davis JoVE 63028 Immunology and Infection
Cellefri skaleret produktion og adjuvans tilsætning til et rekombinant større ydre membranprotein fra Chlamydia muridarum til vaccineudvikling Sean F. Gilmore*1, Wei He*1, Angela C. Evans1, Delia F. Tifrea2, Sukumar Pal2, Brent Segelke1, Sandra K. G. Peters1, B. Dillon Vannest1, Nicholas O. Fischer1, Amy Rasley1, Luis M. de la Maza2, Matthew A. Coleman1,3 1Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, 2Department of Pathology and Laboratory Medicine, University of California, 3School of Medicine, Radiation Oncology, University of California Davis JoVE 63028 Immunology and Infection